|
2015
|
Invention
|
Glut4 endocytosis inhibitor. The present invention provides a therapeutic drug for diabetes conta... |
|
|
Invention
|
Glut4 endocytosis inhibitor. The present invention provides: a therapeutic agent for diabetes, pa... |
|
|
Invention
|
Agent for treating diabetes. The present invention provides a prophylactic and/or therapeutic dru... |
|
|
Invention
|
Agent for treating diabetes. Provided are agents and the like for preventing and/or treating diab... |
|
2014
|
Invention
|
Anti-cancer agent containing a diacylphosphatidylethanolamine as an active ingredient. The presen... |
|
|
Invention
|
Antidepressant combination drug. The combined use of 1,2-dilinoleoyl-sn-glycero-3-phosphocholine ... |
|
|
Invention
|
Antidepressant combination drug. Exceptional antidepressant action, improving action on cognitiv... |
|
|
Invention
|
Anticancer drug.
An anti-cancer agent and a cancer cell death inducing agent, containing an inos... |
|
|
Invention
|
Anticancer agent. The present invention aims to provide a compound having an anticancer action co... |
|
|
Invention
|
Cell membrane transport promoter for selective 5-ht1a serotonin receptors.
Provided is a cellula... |
|
|
Invention
|
Cell membrane transport promoter for selective 5-ht1a serotonin receptors. Provided is a cell mem... |
|
|
Invention
|
Elastin synthesis/regeneration promoting agent. 8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-oc... |
|
|
Invention
|
Elastin synthesis/regeneration promoting agent. 8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-oc... |
|
|
Invention
|
Inhibitor of τ protein phosphorylation. 1-42, and is useful as a therapeutic drug for Alzheimer-t... |
|
|
Invention
|
Inhibitor of τprotein phosphorylation. A novel use of 8-[2-(2-pentyl-cyclopropylmethyl)-cycloprop... |
|
|
Invention
|
Phospholipid compound containing unsaturated fatty acid derivative having cyclopropane ring. The ... |
|
2011
|
Invention
|
Concomitant drug for improving cognitive function.
The present invention aims to provide a medic... |
|
|
Invention
|
Concomitant drug for improving cognitive function. The purpose of the invention is to provide a d... |
|
|
Invention
|
Pkc-ε activator. The present invention aims to obtain an optical isomer of DCP-LA, which shows mo... |
|
|
Invention
|
Pkc-ε activator. The purpose of the present invention is to obtain a DCP-LA enantiomer that exhib... |
|
2001
|
Invention
|
Carboxylic acid compound having cyclopropane ring. A carboxylic acid compound having cyclopropane... |
